The Scientist

» microbiology, evolution and disease/medicine

Most Recent

image: Skin-to-Liver Cell Shortcut

Skin-to-Liver Cell Shortcut

By | February 23, 2014

Researchers use an adapted reprogramming technique to generate hepatocytes for the repopulation of an injured mouse liver.

1 Comment

image: How a Microbe Resists Its Own Antibiotics

How a Microbe Resists Its Own Antibiotics

By | February 20, 2014

Researchers reveal the molecular mechanisms of Streptomyces platensis’s defense from its own antibiotics, which inhibit fatty acid synthesis in other microbes.

0 Comments

image: OCD-Linked Canine Genes

OCD-Linked Canine Genes

By | February 19, 2014

Dogs can suffer from obsessive compulsive disorder just like some humans do, and now researchers have identified a genetic basis for their spastic behavior.

3 Comments

image: Bodybuilders Take Breast Cancer Drug

Bodybuilders Take Breast Cancer Drug

By | February 17, 2014

Tamoxifen, an endocrine therapy for women with breast cancer, is found in a supplement marketed to bodybuilders.

0 Comments

image: Week in Review: February 10–14

Week in Review: February 10–14

By | February 14, 2014

First Ancient North American genome; cannabinoids connect hunger with olfaction and eating; biotechs explore crowdfunding; confronting creationism

0 Comments

image: Pesticide Linked to Alzheimer’s

Pesticide Linked to Alzheimer’s

By | February 10, 2014

Researchers find that DDT may increase the risk of the neurodegenerative disease.

0 Comments

image: Triglyceride Clock

Triglyceride Clock

By | February 10, 2014

The timing of meals affects the levels of lipids in the livers of mice, according to a study.

0 Comments

image: Neural Target for Autism?

Neural Target for Autism?

By | February 7, 2014

Mouse and rat models of the developmental disorder responded positively to a drug given to their mothers a day before birth.

0 Comments

image: Opinion: Confronting Creationism

Opinion: Confronting Creationism

By | February 7, 2014

Five reasons why scientists should stay out of debates over evolution.

53 Comments

image: $230M for Big Disease

$230M for Big Disease

By | February 5, 2014

The National Institutes of Health is partnering with 10 drug companies to find new treatments for Alzheimer’s disease, diabetes, rheumatoid arthritis, and lupus.

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech